Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DR

David B. Ring — 33 Patents

CHChiron: 22 patents #11 of 583Top 2%
CECetus: 8 patents #17 of 213Top 8%
CBCreative Biomolecules: 4 patents #15 of 47Top 35%
COCetus Oncology: 2 patents #7 of 56Top 15%
AIAvant Immunotherapeutics: 1 patents #16 of 50Top 35%
DIDana-Farber Cancer Institute: 1 patents #698 of 1,343Top 55%
NDNovartis Vaccines And Diagnostics: 1 patents #231 of 420Top 60%
Redwood City, CA: #233 of 5,061 inventorsTop 5%
California: #15,252 of 386,348 inventorsTop 4%
Overall (All Time): #105,480 of 4,157,543Top 3%
33 Patents All Time
David B. Ring has been granted 33 US patents while listed as an inventor at Chiron. The first was granted in 1986 and the most recent in September 2008. David B. Ring ranks #105,480 of 4,157,543 US inventors in our database (top 2.5%). Patent records list David B. Ring in Redwood City, CA, US.

Issued Patents All Time

Showing 1–25 of 33 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7425557 Inhibitors of glycogen synthase kinase 3 John M. Nuss, Stephen Harrison, Rustum Boyce, Kirk W. Johnson, Keith B. Pfister +5 more 2008-09-16 $50,978,000
7138497 Biosynthetic binding proteins for immuno-targeting Lou L. Houston 2006-11-21
7053097 Inhibitors of glycogen synthase 3 kinase Peter G. Schultz, Stephen Harrison, Andrew M. Bray 2006-05-30
7045519 Inhibitors of glycogen synthase kinase 3 John M. Nuss, Stephen Harrison, Rustum Boyce, Kirk W. Johnson, Keith B. Pfister +5 more 2006-05-16
7037918 Inhibitors of glycogen synthase kinase 3 John M. Nuss, Stephen Harrison, Rustum Boyce, Sean P. Brown, Dane Goff +8 more 2006-05-02
6489344 Inhibitors of glycogen synthase kinase 3 John M. Nuss, Stephen Harrison, Rustum Boyce, Sean P. Brown, Dane Goff +8 more 2002-12-03 $20,641,000
6479284 Humanized antibody and uses thereof Wayne A. Marasco, Joyce Lavecchio, Abner Mhashilkar, Urban Ramstedt, Bridget Eberhardt +1 more 2002-11-12
6417185 Inhibitors of glycogen synthase kinase 3 Dane Goff, Stephen Harrison, John M. Nuss, Xiaohui Zhou 2002-07-09 $15,905,000
6153618 Inhibitors of glycogen synthase 3 kinase Peter G. Schultz, Stephen Harrison, Andrew M. Bray 2000-11-28 $168,143,000
6143873 Monoclonal anti-multiple drug resistance antibody, methods of production and uses thereof Tian Shi 2000-11-07 $165,707,000
6106833 Bispecific antibodies, methods of production and use thereof Tian Shi 2000-08-22 $91,497,000
6057117 Identification and use of selective inhibitors of glycogen synthase kinase 3 Stephen Harrison 2000-05-02 $33,526,000
6054561 Antigen-binding sites of antibody molecules specific for cancer antigens 2000-04-25 $66,221,000
5959084 Bispecific antibodies, methods of production and uses thereof Tian Shi 1999-09-28 $13,247,000
5948647 Nucleic acids encoding antigen-binding sites specific for cancer antigens 1999-09-07 $35,565,000
5877305 DNA encoding biosynthetic binding protein for cancer marker James S. Huston, L. L. Houston, Hermann Oppermann 1999-03-02 $20,101,000
5849877 Antigen-binding sites of antibody molecules specific for cancer antigens 1998-12-15 $14,369,000
5837846 Biosynthetic binding proteins for immuno-targeting James S. Huston, L. L. Houston, Hermann Oppermann 1998-11-17
5811267 Isolated nucleic acid molecules encoding antigen binding sites of antibody molecules specific for cancer antigens 1998-09-22 $8,125,000
5753204 Biosynthetic binding proteins for immunotargeting James S. Huston, L. L. Houston, Hermann Oppermann 1998-05-19
5725850 Use of CSF-1 to treat tumor burden Peter Ralph, Kong T. Chong, James J. Devlin, Robert Zimmerman, Sharon Lea Aukerman +1 more 1998-03-10 $13,486,000
5705614 Methods of producing antigen forks 1998-01-06 $8,593,000
5629197 Monoclonal anti-human breast cancer antibodies Arthur E. Frankel, Michael J. Bjorn 1997-05-13
5534254 Biosynthetic binding proteins for immuno-targeting James S. Huston, L. L. Houston, Hermann Oppermann 1996-07-09
5169774 Monoclonal anti-human breast cancer antibodies Arthur E. Frankel, Walter J. Laird 1992-12-08